News
Contacts
University of Cambridge, Cambridge University Hospitals NHS Foundation Trust
Department of Oncology
Programme Lead
University of Cambridge
Cancer Research UK Cambridge Institute
University of Cambridge
Department of Oncology
Programme Manager
Experimental Cancer Medicine Demystified
27 Sep 2024
Join in person or online our annual open event for patients, carers, and anyone with an interest in cancer research on Friday 27 September, 10:00–16:00 at the CRUK Cambridge Institute, Cambridge Biomedical Campus.
Summer 2024 newsletter from the Cambridge ECMC
24 Jul 2024
Local news, network initiatives, recruiting trials, events, opportunities and funding related to early phase cancer clinical trials and translational research
Get hands-on with cancer research in Cambridge!
12 Feb 2024
Join us on Saturday 16 March from 11am – 4pm for the Big Biomedical Campus day at the Cambridge Academy for Science and Technology.
Collaborating to empower patient groups
7 Feb 2024
A workshop to develop a new collaboration between patient groups at Barts Cancer Institute and the Cancer Research UK Cambridge Centre took place this week.
Initial trial results suggest new treatment combination for some breast cancer patients
8 Dec 2023
A Cambridge-led trial testing a potential new treatment combination for post-menopausal women with hormone driven breast cancer reports positive findings at the international San Antonio Breast Cancer Symposium.
Experimental Cancer Medicine Demystified 2023
20 Oct 2023
Register now: all welcome to join us on Friday 20 October, 9:30–16:00, at the CRUK Cambridge Institute lecture theatre, Cambridge Biomedical Campus for our annual open event.
First patient recruited in Cambridge for novel cancer immunotherapy trial
31 Aug 2023
A new clinical trial is being carried out by CRUK’s Centre for Drug Development to evaluate the orally available drug, HTL0039732, for advanced solid tumours.
Summer 2023 newsletter from the Cambridge ECMC
25 Jul 2023
Local news, network initiatives, recruiting trials, events, opportunities and funding related to early phase cancer clinical trials and translational research
